Oncology PracticeFDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeNovel SERD, LSZ102, shows promise for pretreated ER+ breast cancerJune 30, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeFDA approves in-home breast cancer treatmentJune 30, 2020Breast CancerMetastatic Breast Cancer
Key Studies in Metastatic Breast Cancer From ASCO 2020June 22, 2020ASCO Breast CancerBreast CancerMetastatic Breast Cancer
Oncology Practice‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeTILs and PET-CT can predict pCR in HER2-positive metastatic breast cancerJune 2, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeTreating primary tumor doesn’t improve OS in stage IV breast cancerJune 1, 2020Breast CancerASCO Breast CancerMetastatic Breast Cancer
Oncology PracticePyrotinib bests lapatinib in HER2+ metastatic breast cancerMay 31, 2020Breast CancerMetastatic Breast CancerASCO Breast Cancer
Oncology PracticeExpanding the role of PARP inhibitors in breast cancerMay 31, 2020Breast CancerASCO Breast CancerMetastatic Breast Cancer
Oncology PracticeTucatinib improves PFS, OS in HER2+ breast cancer with brain metastasesMay 30, 2020Breast CancerASCO Breast CancerMetastatic Breast Cancer
Oncology PracticePembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancerMay 29, 2020Breast CancerASCO Breast CancerMetastatic Breast Cancer
Oncology PracticeLOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBCMay 28, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeMammography cuts risk for fatal breast cancers: New dataMay 13, 2020Breast CancerPreventive CarePatient & Survivor CareMetastatic Breast Cancer
Oncology PracticeNovel immune activator boosts immunotherapy benefit in TNBCMay 1, 2020Breast CancerMetastatic Breast Cancer
Oncology PracticeEMBRACA shows no overall survival benefit with talazoparibApril 29, 2020Breast CancerMetastatic Breast Cancer
